We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company for Leuprolide Acetate Injection.
Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release
June 7, 2022
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month